Sarcopenia, a hallmark of cancer cachexia, is associated with poor outcomes in chimeric antigen receptor (CAR) T-cell therapy ...

It is obviously more pronounced in high-volume pursuits such as beer drinking, where the greater volumes of water consumed ...

Electrical & Biomedical Engineering Associate Professor Josette El Zaklit’s research could improve the health of pilots and ...

What you eat before and after a workout may make or break your performance. However, there's more than one way to take care ...

“Taking a collagen supplement daily can help to replenish natural collagen levels in the body, which naturally decline by ...

The researchers behind the study used magnetic resonance imaging (MRI) to show that eating highly processed foods increases ...

The 18-meter walk test (18MWT) effectively evaluates disease severity and predicts clinical outcomes in pulmonary arterial ...

In 2014, the researchers of the recent PLoS One study published a meta-analysis revealing that physical exercise had a ...

Keros' cash and cash equivalents as of March 31, 2025 was $720.5 million compared to $559.9 million as of December 31, 2024.

The other option is to make a generally humanoid-shaped robot that is still different enough that it does not enter the ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.